{"transactions":[{"id":789135,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-05-07T20:01:55.000Z","date":"2026-05-05","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":35.4,"value":1062000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":55755,"source":{"system":"sec-edgar","filing":"0001193125-26-211833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526211833/ownership.xml","form_type":"4"}},{"id":854916,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:12:26.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":17295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,295 vested on March 5, 2026, 17,295 vesting on each of March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,295 vested on March 5, 2026, 17,295 vesting on each of March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":51887,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17295},"source":{"system":"sec-edgar","filing":"0001193125-26-098512","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098512/ownership.xml","form_type":"4"}},{"id":854915,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:12:26.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":17295,"price":31.6684,"value":547704.978,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":85755,"source":{"system":"sec-edgar","filing":"0001193125-26-098512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098512/ownership.xml","form_type":"4"}},{"id":854914,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:12:26.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":17295,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":103050,"source":{"system":"sec-edgar","filing":"0001193125-26-098512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098512/ownership.xml","form_type":"4"}},{"id":857165,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"grant","planned":true,"acquired":true,"shares":33424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Restricted share units were granted on March 4, 2026, with 8,356 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Restricted share units were granted on March 4, 2026, with 8,356 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":33424,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33424},"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":857164,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":20461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on each of March 4, 2025 and March 4, 2026, 20,461 vesting on March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on each of March 4, 2025 and March 4, 2026, 20,461 vesting on March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":40923,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20461},"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":857163,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":33512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33512},"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":857162,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":37372,"price":32.9474,"value":1231310.2328,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.905 to $33.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":85755,"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":857161,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":20461,"price":32.4645,"value":664256.1345,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.095 to $33.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":123127,"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":857160,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":true,"shares":20461,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":143588,"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":857159,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":33512,"price":32.4645,"value":1087950.324,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.095 to $33.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":123127,"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":857158,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":true,"shares":33512,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":156639,"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":859927,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-05T21:09:51.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":false,"shares":141478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on March 3, 2026, following satisfaction of the time-based vesting criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on March 3, 2026, following satisfaction of the time-based vesting criteria."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":141478},"source":{"system":"sec-edgar","filing":"0001193125-26-093945","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093945/ownership.xml","form_type":"4"}},{"id":859926,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-05T21:09:51.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":false,"shares":62250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 62,250 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 62,253 vesting on March 4, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 62,250 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 62,253 vesting on March 4, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":62253,"derivative":{"underlying":"Ordinary Shares","underlying_shares":62250},"source":{"system":"sec-edgar","filing":"0001193125-26-093945","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093945/ownership.xml","form_type":"4"}},{"id":859925,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:09:51.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":66735,"price":32.3599,"value":2159537.9265,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents (1) with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting, and (2) with respect to the restricted share units granted subject to performance criteria, the reporting person sold such number of shares required to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72 to $32.865, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":123127,"source":{"system":"sec-edgar","filing":"0001193125-26-093945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093945/ownership.xml","form_type":"4"}},{"id":859924,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:09:51.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":true,"shares":141478,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":189862,"source":{"system":"sec-edgar","filing":"0001193125-26-093945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093945/ownership.xml","form_type":"4"}},{"id":859923,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:09:51.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":62250,"price":32.3599,"value":2014403.775,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents (1) with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting, and (2) with respect to the restricted share units granted subject to performance criteria, the reporting person sold such number of shares required to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72 to $32.865, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":48384,"source":{"system":"sec-edgar","filing":"0001193125-26-093945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093945/ownership.xml","form_type":"4"}},{"id":859922,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:09:51.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":true,"shares":62250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":110634,"source":{"system":"sec-edgar","filing":"0001193125-26-093945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093945/ownership.xml","form_type":"4"}},{"id":928298,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2026-01-29T21:02:56.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":141478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":141478,"derivative":{"underlying":"Ordinary Shares","underlying_shares":141478},"source":{"system":"sec-edgar","filing":"0001193125-26-029306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526029306/ownership.xml","form_type":"4"}},{"id":973366,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Stock Options (right to buy)","published_at":"2025-12-11T21:09:26.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":false,"shares":15011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock options were granted on September 18, 2017, with 7,505 vested on September 18, 2018, and 7,506 vested on September 18, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":16.99,"expiration_date":"2027-09-18","underlying":"Ordinary Shares","underlying_shares":15011},"source":{"system":"sec-edgar","filing":"0001193125-25-315938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525315938/ownership.xml","form_type":"4"}},{"id":973365,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Stock Options (right to buy)","published_at":"2025-12-11T21:09:26.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":false,"shares":100457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock options were granted on February 9, 2018, with 33,485 vested on each of February 9, 2020 and February 9, 2021, and 33,487 vested on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":18.61,"expiration_date":"2028-02-09","underlying":"Ordinary Shares","underlying_shares":100457},"source":{"system":"sec-edgar","filing":"0001193125-25-315938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525315938/ownership.xml","form_type":"4"}},{"id":973364,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-12-11T21:09:26.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":115468,"price":28.6757,"value":3311125.7276,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.635 to $28.765, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":48384,"source":{"system":"sec-edgar","filing":"0001193125-25-315938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525315938/ownership.xml","form_type":"4"}},{"id":973363,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-12-11T21:09:26.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":15011,"price":16.99,"value":255036.89,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":163852,"source":{"system":"sec-edgar","filing":"0001193125-25-315938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525315938/ownership.xml","form_type":"4"}},{"id":973362,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-12-11T21:09:26.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":100457,"price":18.61,"value":1869504.77,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":148841,"source":{"system":"sec-edgar","filing":"0001193125-25-315938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312525315938/ownership.xml","form_type":"4"}},{"id":1218507,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2025-03-07T21:05:44.000Z","date":"2025-03-05","kind":"grant","planned":true,"acquired":true,"shares":69182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 5, 2025, with 17,295 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 5, 2025, with 17,295 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":69182,"derivative":{"underlying":"Ordinary Shares","underlying_shares":69182},"source":{"system":"sec-edgar","filing":"0000950170-25-035489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025035489/ownership.xml","form_type":"4"}},{"id":1218506,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2025-03-07T21:05:44.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":false,"shares":22576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 22,576 vested on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 22,576 vested on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22576},"source":{"system":"sec-edgar","filing":"0000950170-25-035489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025035489/ownership.xml","form_type":"4"}},{"id":1218505,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-07T21:05:44.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":48385,"price":15.901,"value":769369.885,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.9 to $15.905, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":48384,"source":{"system":"sec-edgar","filing":"0000950170-25-035489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025035489/ownership.xml","form_type":"4"}},{"id":1218504,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-07T21:05:44.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":22576,"price":15.9139,"value":359272.2064,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.795 to $16.01, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":96769,"source":{"system":"sec-edgar","filing":"0000950170-25-035489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025035489/ownership.xml","form_type":"4"}},{"id":1218503,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-07T21:05:44.000Z","date":"2025-03-05","kind":"exercise","planned":true,"acquired":true,"shares":22576,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":119345,"source":{"system":"sec-edgar","filing":"0000950170-25-035489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025035489/ownership.xml","form_type":"4"}},{"id":1220805,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":false,"shares":183169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Restricted share units were granted on January 28, 2025 pursuant to the satisfaction of performance criteria and vested on March 4, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Restricted share units were granted on January 28, 2025 pursuant to the satisfaction of performance criteria and vested on March 4, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":183169},"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220804,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":false,"shares":20461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on March 4, 2025, 20,461 vesting on each of March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on March 4, 2025, 20,461 vesting on each of March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":61384,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20461},"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220803,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":false,"shares":33512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 33,512 vesting on March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 33,512 vesting on March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":33512,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33512},"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220802,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":30015,"price":15.9132,"value":477634.698,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.68 to $16.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":96769,"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220801,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":56385,"price":15.7346,"value":887195.421,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $16.015, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":126784,"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220800,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":true,"shares":183169,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":183169,"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220799,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":7108,"price":15.9132,"value":113111.0256,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.68 to $16.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220798,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":13353,"price":15.7346,"value":210104.1138,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $16.015, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7108,"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220797,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":true,"shares":20461,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":20461,"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220796,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":11641,"price":15.9132,"value":185245.5612,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.68 to $16.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220795,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":21870,"price":15.7346,"value":344115.702,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $16.015, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11641,"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1220794,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:06:05.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":true,"shares":33512,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":33512,"source":{"system":"sec-edgar","filing":"0000950170-25-034607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034607/ownership.xml","form_type":"4"}},{"id":1224659,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2025-03-05T21:12:10.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":false,"shares":62250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 62,250 vested on each of March 3, 2024 and March 3, 2025, 62,250 vesting on March 3, 2026, and 62,253 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 62,250 vested on each of March 3, 2024 and March 3, 2025, 62,250 vesting on March 3, 2026, and 62,253 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":124503,"derivative":{"underlying":"Ordinary Shares","underlying_shares":62250},"source":{"system":"sec-edgar","filing":"0000950170-25-033566","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033566/ownership.xml","form_type":"4"}},{"id":1224658,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:12:10.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":12936,"price":15.5576,"value":201253.1136,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.455 to $15.75, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-033566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033566/ownership.xml","form_type":"4"}},{"id":1224657,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:12:10.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":49314,"price":16.1855,"value":798171.747,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.86 to $16.53, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12936,"source":{"system":"sec-edgar","filing":"0000950170-25-033566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033566/ownership.xml","form_type":"4"}},{"id":1224656,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:12:10.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":62250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":62250,"source":{"system":"sec-edgar","filing":"0000950170-25-033566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033566/ownership.xml","form_type":"4"}},{"id":1291307,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2025-01-30T21:06:14.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":183169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 4, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 4, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":183169,"derivative":{"underlying":"Ordinary Shares","underlying_shares":183169},"source":{"system":"sec-edgar","filing":"0000950170-25-011080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025011080/ownership.xml","form_type":"4"}},{"id":1435394,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-08-13T20:09:34.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":98943,"price":17.2973,"value":1711446.7539,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-096198","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024096198/ownership.xml","form_type":"4"}},{"id":1590215,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2024-03-07T21:20:32.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":false,"shares":55226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on January 30, 2024 pursuant to the satisfaction of performance criteria and vested on March 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on January 30, 2024 pursuant to the satisfaction of performance criteria and vested on March 5, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":55226},"source":{"system":"sec-edgar","filing":"0000950170-24-027986","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024027986/ownership.xml","form_type":"4"}},{"id":1590214,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2024-03-07T21:20:32.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":false,"shares":22576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 22,576 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 22,576 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":22576,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22576},"source":{"system":"sec-edgar","filing":"0000950170-24-027986","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024027986/ownership.xml","form_type":"4"}},{"id":1590213,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-07T21:20:32.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":26053,"price":13.5154,"value":352116.7162,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.41 to $13.61, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":98943,"source":{"system":"sec-edgar","filing":"0000950170-24-027986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024027986/ownership.xml","form_type":"4"}},{"id":1590212,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-07T21:20:32.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":true,"shares":55226,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":124996,"source":{"system":"sec-edgar","filing":"0000950170-24-027986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024027986/ownership.xml","form_type":"4"}},{"id":1590211,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-07T21:20:32.000Z","date":"2024-03-05","kind":"sale","planned":true,"acquired":false,"shares":22576,"price":13.5154,"value":305123.6704,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.41 to $13.61, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":69770,"source":{"system":"sec-edgar","filing":"0000950170-24-027986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024027986/ownership.xml","form_type":"4"}},{"id":1590210,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-07T21:20:32.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":true,"shares":22576,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":92346,"source":{"system":"sec-edgar","filing":"0000950170-24-027986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024027986/ownership.xml","form_type":"4"}},{"id":1600197,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:21:46.000Z","date":"2024-03-04","kind":"grant","planned":true,"acquired":true,"shares":81845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 20,461 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 20,461 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":81845,"derivative":{"underlying":"Ordinary Shares","underlying_shares":81845},"source":{"system":"sec-edgar","filing":"0000950170-24-025982","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025982/ownership.xml","form_type":"4"}},{"id":1600196,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:21:46.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":false,"shares":33512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":67024,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33512},"source":{"system":"sec-edgar","filing":"0000950170-24-025982","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025982/ownership.xml","form_type":"4"}},{"id":1600195,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:21:46.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":false,"shares":62250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 3, 2023, with 62,250 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 62,253 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 3, 2023, with 62,250 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 62,253 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":186753,"derivative":{"underlying":"Ordinary Shares","underlying_shares":62250},"source":{"system":"sec-edgar","filing":"0000950170-24-025982","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025982/ownership.xml","form_type":"4"}},{"id":1600194,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:21:46.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":33512,"price":13.3373,"value":446959.5976,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":69770,"source":{"system":"sec-edgar","filing":"0000950170-24-025982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025982/ownership.xml","form_type":"4"}},{"id":1600193,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:21:46.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":true,"shares":33512,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":103282,"source":{"system":"sec-edgar","filing":"0000950170-24-025982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025982/ownership.xml","form_type":"4"}},{"id":1600192,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:21:46.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":62250,"price":13.3373,"value":830246.925,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":69770,"source":{"system":"sec-edgar","filing":"0000950170-24-025982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025982/ownership.xml","form_type":"4"}},{"id":1600191,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:21:46.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":true,"shares":62250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":132020,"source":{"system":"sec-edgar","filing":"0000950170-24-025982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024025982/ownership.xml","form_type":"4"}},{"id":1608751,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2024-03-01T11:43:41.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":false,"shares":20599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 28, 2020 with 20,598 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 20,599 vested on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 28, 2020 with 20,598 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 20,599 vested on February 28, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20599},"source":{"system":"sec-edgar","filing":"0000950170-24-023522","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024023522/ownership.xml","form_type":"4"}},{"id":1608750,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-01T11:43:41.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":20599,"price":13.116,"value":270176.484,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.19, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":69770,"source":{"system":"sec-edgar","filing":"0000950170-24-023522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024023522/ownership.xml","form_type":"4"}},{"id":1608749,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2024-03-01T11:43:41.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":true,"shares":20599,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":90369,"source":{"system":"sec-edgar","filing":"0000950170-24-023522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024023522/ownership.xml","form_type":"4"}},{"id":1664410,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2024-02-01T12:28:24.000Z","date":"2024-01-30","kind":"grant","planned":false,"acquired":true,"shares":55226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 5, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":55226,"derivative":{"underlying":"Ordinary Shares","underlying_shares":55226},"source":{"system":"sec-edgar","filing":"0000950170-24-009616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024009616/ownership.xml","form_type":"4"}},{"id":1964382,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2023-03-08T21:02:54.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":54007,"price":9.4279,"value":509172.5953,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.725, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":69770,"source":{"system":"sec-edgar","filing":"0001209191-23-017154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123017154/doc4.xml","form_type":"4"}},{"id":1964381,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2023-03-08T21:02:54.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":18002,"price":9.9309,"value":178776.0618,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $10.045, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":123777,"source":{"system":"sec-edgar","filing":"0001209191-23-017154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123017154/doc4.xml","form_type":"4"}},{"id":1967218,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:03:16.000Z","date":"2023-03-05","kind":"exercise","acquired":false,"shares":22576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 22,576 vested on each of March 5, 2022 and March 5, 2023, and 22,576 vesting on each of March 5, 2024 and March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 22,576 vested on each of March 5, 2022 and March 5, 2023, and 22,576 vesting on each of March 5, 2024 and March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":45152,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22576},"source":{"system":"sec-edgar","filing":"0001209191-23-016686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016686/doc4.xml","form_type":"4"}},{"id":1967217,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:03:16.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":33512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":100536,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33512},"source":{"system":"sec-edgar","filing":"0001209191-23-016686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016686/doc4.xml","form_type":"4"}},{"id":1967216,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:03:16.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":15921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 15,920 vested on each of March 4, 2021 and March 4, 2022, and 15,921 vested on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 15,920 vested on each of March 4, 2021 and March 4, 2022, and 15,921 vested on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15921},"source":{"system":"sec-edgar","filing":"0001209191-23-016686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016686/doc4.xml","form_type":"4"}},{"id":1967215,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:03:16.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":249003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 62,250 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 62,253 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 62,250 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 62,253 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":249003,"derivative":{"underlying":"Ordinary Shares","underlying_shares":249003},"source":{"system":"sec-edgar","filing":"0001209191-23-016686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016686/doc4.xml","form_type":"4"}},{"id":1967214,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:03:16.000Z","date":"2023-03-05","kind":"exercise","acquired":true,"shares":22576,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":141779,"source":{"system":"sec-edgar","filing":"0001209191-23-016686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016686/doc4.xml","form_type":"4"}},{"id":1967213,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:03:16.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":33512,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":119203,"source":{"system":"sec-edgar","filing":"0001209191-23-016686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016686/doc4.xml","form_type":"4"}},{"id":1967212,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2023-03-07T21:03:16.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":15921,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":85691,"source":{"system":"sec-edgar","filing":"0001209191-23-016686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016686/doc4.xml","form_type":"4"}},{"id":1981771,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2023-03-02T12:33:18.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":50242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on February 7, 2023 pursuant to the satisfaction of performance criteria and vested on February 28, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on February 7, 2023 pursuant to the satisfaction of performance criteria and vested on February 28, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":50242},"source":{"system":"sec-edgar","filing":"0001209191-23-014435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014435/doc4.xml","form_type":"4"}},{"id":1981770,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2023-03-02T12:33:18.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":20598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 20,598 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 20,599 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 20,598 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 20,599 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":20599,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20598},"source":{"system":"sec-edgar","filing":"0001209191-23-014435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014435/doc4.xml","form_type":"4"}},{"id":1981769,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:33:18.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":23654,"price":9.8866,"value":233857.6364,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $9.94, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":69770,"source":{"system":"sec-edgar","filing":"0001209191-23-014435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014435/doc4.xml","form_type":"4"}},{"id":1981768,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:33:18.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":50242,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":93424,"source":{"system":"sec-edgar","filing":"0001209191-23-014435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014435/doc4.xml","form_type":"4"}},{"id":1981767,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:33:18.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":20598,"price":9.8866,"value":203644.1868,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $9.94, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":43182,"source":{"system":"sec-edgar","filing":"0001209191-23-014435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014435/doc4.xml","form_type":"4"}},{"id":1981766,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2023-03-02T12:33:18.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":20598,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":63780,"source":{"system":"sec-edgar","filing":"0001209191-23-014435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123014435/doc4.xml","form_type":"4"}},{"id":2025599,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2023-02-09T12:01:13.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":50242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 28, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 28, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":50242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":50242},"source":{"system":"sec-edgar","filing":"0001209191-23-007949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123007949/doc4.xml","form_type":"4"}},{"id":2345908,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":22576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Restricted share units were granted on March 5, 2021, with 22,576 having vested on March 5, 2022 and 22,576 vesting on each of March 5, 2023, March 5, 2024 and March\n5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Restricted share units were granted on March 5, 2021, with 22,576 having vested on March 5, 2022 and 22,576 vesting on each of March 5, 2023, March 5, 2024 and March\n5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":67728,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22576},"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2345907,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":134048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":134048,"derivative":{"underlying":"Ordinary Shares","underlying_shares":134048},"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2345906,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":43358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":43358},"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2345905,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":15920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2019, with 15,920 having vested on each of March 4, 2021 and March 4, 2022, and 15,921 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2019, with 15,920 having vested on each of March 4, 2021 and March 4, 2022, and 15,921 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":15921,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15920},"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2345904,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":22576,"price":7.3667,"value":166310.6192,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":43182,"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2345903,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":22576,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":65758,"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2345902,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":20456,"price":7.4825,"value":153062.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":43182,"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2345901,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":43358,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":63638,"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2345900,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":15920,"price":7.4825,"value":119121.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":20280,"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2345899,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-03-08T21:03:18.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":15920,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":36200,"source":{"system":"sec-edgar","filing":"0001209191-22-017034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122017034/doc4.xml","form_type":"4"}},{"id":2363028,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2022-03-02T12:41:56.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":20598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 28, 2020, with 20,598 having vested on each of February 28, 2021 and February 28, 2022, 20,598 vesting on\nFebruary 28, 2023, and 20,599 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 28, 2020, with 20,598 having vested on each of February 28, 2021 and February 28, 2022, 20,598 vesting on\nFebruary 28, 2023, and 20,599 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":41197,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20598},"source":{"system":"sec-edgar","filing":"0001209191-22-014466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014466/doc4.xml","form_type":"4"}},{"id":2363027,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-03-02T12:41:56.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":20598,"price":8.1422,"value":167713.0356,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.035 to $8.255,\ninclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full\ninformation regarding the number of shares sold at each separate price."}],"balance_after":20280,"source":{"system":"sec-edgar","filing":"0001209191-22-014466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014466/doc4.xml","form_type":"4"}},{"id":2363026,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-03-02T12:41:56.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":20598,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":40878,"source":{"system":"sec-edgar","filing":"0001209191-22-014466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122014466/doc4.xml","form_type":"4"}},{"id":2405254,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2022-02-10T21:05:13.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":43358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on March 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on March 4, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":43358,"derivative":{"underlying":"Ordinary Shares","underlying_shares":43358},"source":{"system":"sec-edgar","filing":"0001209191-22-008409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008409/doc4.xml","form_type":"4"}},{"id":2405253,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2022-02-10T21:05:13.000Z","date":"2022-02-09","kind":"exercise","acquired":false,"shares":13135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on February 9, 2018, with 13,135 having vested on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on February 9, 2018, with 13,135 having vested on each of February 9, 2020, February 9, 2021 and February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13135},"source":{"system":"sec-edgar","filing":"0001209191-22-008409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008409/doc4.xml","form_type":"4"}},{"id":2405252,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-02-10T21:05:13.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":13135,"price":9.0605,"value":119009.6675,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.075,\ninclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full\ninformation regarding the number of shares sold at each separate price."}],"balance_after":20280,"source":{"system":"sec-edgar","filing":"0001209191-22-008409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008409/doc4.xml","form_type":"4"}},{"id":2405251,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2022-02-10T21:05:13.000Z","date":"2022-02-09","kind":"exercise","acquired":true,"shares":13135,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":33415,"source":{"system":"sec-edgar","filing":"0001209191-22-008409","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919122008409/doc4.xml","form_type":"4"}},{"id":2804314,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:02:41.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":90304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 5, 2021, with 22,576 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 5, 2021, with 22,576 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":90304,"derivative":{"underlying":"Ordinary Shares","underlying_shares":90304},"source":{"system":"sec-edgar","filing":"0001209191-21-018508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018508/doc4.xml","form_type":"4"}},{"id":2804313,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Restricted Share Units","published_at":"2021-03-08T21:02:41.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":15920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 4, 2019, with 15,920 vesting on each of March 4, 2021 and March 4, 2022 and 15,921 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 4, 2019, with 15,920 vesting on each of March 4, 2021 and March 4, 2022 and 15,921 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":31841,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15920},"source":{"system":"sec-edgar","filing":"0001209191-21-018508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018508/doc4.xml","form_type":"4"}},{"id":2804312,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. VP, European Commercial"}}],"security":"Ordinary Shares","published_at":"2021-03-08T21:02:41.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":7513,"price":10.5844,"value":79520.5972,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.510 to $10.700, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":20280,"source":{"system":"sec-edgar","filing":"0001209191-21-018508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919121018508/doc4.xml","form_type":"4"}}],"next_cursor":"2021-03-08T21:02:41.000000Z,2804312"}